Oppenheimer Holdings Inc. reported on TherapeuticsMD Inc (NASDAQ:TXMD), raising its target price to $12.00 today
- Updated: November 27, 2016
TherapeuticsMD Inc (NASDAQ:TXMD) had its stock price target increased to $12.00 by Oppenheimer Holdings Inc. in a report released Tuesday November 22, 2016. The new stock price target indicates a possible upside of 0.68% based on the company's previous stock price.
Just yesterday TherapeuticsMD Inc (NASDAQ:TXMD) traded -0.70% lower at $7.13. TherapeuticsMD Inc’s 50-day moving average is $6.27 and its 200-day moving average is $7.34. The last stock price is down -3.24% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.03% over the same time period. 865,264 shares of TXMD traded hands, down from an average trading volume of 1,869,530
Recent Performance Chart
TherapeuticsMD Inc has with a one year low of $4.39 and a one year high of $11.26 and has a market capitalization of $0.
A total of 5 firms have reported on the company. 3 brokers rating the stock a strong buy, 2 brokers rating the stock a buy, 0 brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally 0 brokerages rating the stock a sell with a average stock price target of $19.30.
Brief Synopsis On TherapeuticsMD Inc (NASDAQ:TXMD)
TherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company's product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.